Literature DB >> 9606174

Cell cycle exit: growth arrest, apoptosis, and tumor suppression revisited.

L Philipson1.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9606174      PMCID： PMC2230366     

Source DB:  PubMed          Journal:  Mol Med        ISSN： 1076-1551            Impact factor:   6.354


× No keyword cloud information.
  35 in total

1.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

Authors:  R Eckner; M E Ewen; D Newsome; M Gerdes; J A DeCaprio; J B Lawrence; D M Livingston
Journal:  Genes Dev       Date:  1994-04-15       Impact factor: 11.361

Review 2.  Transgenic mice and oncogenesis.

Authors:  S Cory; J M Adams
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

3.  Role of the INK4a locus in tumor suppression and cell mortality.

Authors:  M Serrano; H Lee; L Chin; C Cordon-Cardo; D Beach; R A DePinho
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

Review 4.  Gene number, noise reduction and biological complexity.

Authors:  A P Bird
Journal:  Trends Genet       Date:  1995-03       Impact factor: 11.639

5.  The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.

Authors:  I Garkavtsev; I A Grigorian; V S Ossovskaya; M V Chernov; P M Chumakov; A V Gudkov
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

6.  Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300.

Authors:  J S Lee; K M Galvin; R H See; R Eckner; D Livingston; E Moran; Y Shi
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

7.  Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.

Authors:  C Deng; P Zhang; J W Harper; S J Elledge; P Leder
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

8.  Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.

Authors:  S Rowan; R L Ludwig; Y Haupt; S Bates; X Lu; M Oren; K H Vousden
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

9.  Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.

Authors:  F Petrij; R H Giles; H G Dauwerse; J J Saris; R C Hennekam; M Masuno; N Tommerup; G J van Ommen; R H Goodman; D J Peters
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

10.  Regulation of G1 progression by E2A and Id helix-loop-helix proteins.

Authors:  F A Peverali; T Ramqvist; R Saffrich; R Pepperkok; M V Barone; L Philipson
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598
View more
  1 in total

1.  Over-expression of FRZB in gastric cancer cell suppresses proliferation and induces differentiation.

Authors:  Ying Qu; Jian-Fang Li; Qu Cai; Yun-Wei Wang; Qin-Long Gu; Zheng-Gang Zhu; Bing-Ya Liu
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-07       Impact factor: 4.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.